Cancer

Items 2151-2160 of 2225

per page
Set Descending Direction
  1. Ubiquitin-AMC (human) (rec.) (untagged)
    SBB-PS0043
    SBB-PS0043-C05050 µg
    CHF 300.00
    Ubiquitin-AMC (human) (rec.) (untagged)
  2. UBS109
    CAS  1258513-40-4
    AG-CR1-3704
    AG-CR1-3704-M0011 mg
    CHF 90.00
    AG-CR1-3704-50015 x 1 mg
    CHF 190.00
    AG-CR1-3704-M01010 mg
    CHF 320.00
    UBS109
  3. UcH-L3 (human) (rec.) (untagged)
    SBB-DE0023
    SBB-DE0023-C05050 µg
    CHF 287.00
    Michaelis–Menten Kinetics: Ubiquitin Rhodamine 110 serially diluted from 1.6 to 0.05µM was digested with 30pM UcHL3 over time. The assay was carried out in a reaction buffer of 50mM HEPES pH 7.5, 100mM NaCl, 1mM TCEP, 0.1mg/ml BSA, at 25°C. Initial
  4. Ulipristal acetate
    CAS  126784-99-4
    CDX-U0027
    CDX-U0027-M05050 mg
    CHF 170.00
    CDX-U0027-M100100 mg
    CHF 285.00
    Ulipristal acetate
  5. Umbelliferon
    CAS  93-35-6
    CDX-U0001
    CDX-U0001-G02525 g
    CHF 54.00
    CDX-U0001-G100100 g
    CHF 122.00
    Umbelliferon
  6. UNC5B (human):Fc (human) (rec.)
    AG-40B-0037
    AG-40B-0037-C05050 µg
    CHF 290.00
    AG-40B-0037-30503 x 50 µg
    CHF 575.00
  7. Undecylprodigiosin
    CAS  56247-02-0 | 52340-48-4 (parent)
    BVT-0422
    BVT-0422-C250250 µg
    CHF 100.00
    BVT-0422-M0011 mg
    CHF 305.00
    Undecylprodigiosin
  8. URMC-099
    CAS  1229582-33-5
    SYN-1211
    SYN-1211-M0011 mg
    CHF 142.00
    SYN-1211-M0055 mg
    CHF 255.00
    SYN-1211-M01010 mg
    CHF 397.00
    SYN-1211-M05050 mg
    CHF 1'348.00
    SYN-1211-M100100 mgINQ
    URMC-099
  9. Ursodeoxycholic acid
    CAS  128-13-2
    AG-CN2-0411
    AG-CN2-0411-G0011 g
    CHF 52.00
    AG-CN2-0411-G0055 g
    CHF 156.00
    Ursodeoxycholic acid
  10. Ursodeoxycholic acid
    CAS  128-13-2
    CDX-U0019
    CDX-U0019-G0055 g
    CHF 122.00
    CDX-U0019-G02525 g
    CHF 489.00
    Ursodeoxycholic acid

Items 2151-2160 of 2225

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.